Oncolytic Viruses as Anticancer Vaccines

Oncolytic virotherapy has shown impressive results in preclinical studies and first promising therapeutic outcomes in clinical trials as well. Since viruses are known for a long time as excellent vaccination agents, oncolytic viruses are now designed as novel anticancer agents combining the aspect o...

Descripción completa

Detalles Bibliográficos
Autores principales: Woller, Norman, Gürlevik, Engin, Ureche, Cristina-Ileana, Schumacher, Anja, Kühnel, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104469/
https://www.ncbi.nlm.nih.gov/pubmed/25101244
http://dx.doi.org/10.3389/fonc.2014.00188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104469/
https://www.ncbi.nlm.nih.gov/pubmed/25101244
http://dx.doi.org/10.3389/fonc.2014.00188

Ejemplares similares